Cambrium's mission is to trigger the next wave of material innovation by harnessing biology’s molecular building blocks. We fundamentally believe that the ability to align economic and environmental incentives makes biology the most important manufacturing technology of the 21st century. Using our molecular design technology, we create novel material building blocks with previously inaccessible functionalities. Our molecules enable innovators to create products that are better for people, and the planet. We are a highly interdisciplinary team of scientists, engineers, designers and entrepreneurs, united by our vision to create materials that matter. Intrepid, vibrant, and purpose-driven we are on a quest to unlock the power of biology, and reinvent materials from the molecular level.
| Website | https://cambrium.bio |
| Revenue | $5 million |
| Employees | 25 (23 on RocketReach) |
| Founded | 2020 |
| Address | Rheinsberger Straße 77a, Berlin, Berlin 10115, DE |
| Technologies | |
| Industry | Biotechnology Research |
| Keywords | Biomaterials, Synthetic Biology, Biomanufacturing, Biological Materials, Bio-Based Materials, Biotechnology, Material Science, Advanced Materials, Sustainable Materials, Biotechnology Innovation, Next Generation Materials, Biological Engineering, Green Materials, Renewable Materials, Bio-Based Products, Molecular Engineering, Clean Technology, Environmental Sustainability |
| Competitors | Cargill, DuPont, Novozymes, Zymergen, Inc., Amyris, LanzaTech, ZymoChem, BIOMILQ, Ecovative Spawn & Substrate - formerly Lambert Spawn Europa, Geno +37 more (view full list) |
Looking for a particular Cambrium employee's phone or email?
The Cambrium annual revenue was $5 million in 2026.
Mitchell Duffy is the CEO of Cambrium.
23 people are employed at Cambrium.
Cambrium is based in Berlin, Berlin.